Core Viewpoint - The company Jindalai (688057) plans to invest 30 million yuan in Beijing Zhongke Hongtai Medical Technology Co., Ltd., acquiring a 10% stake in the company [1] Group 1: Company Overview - Zhongke Hongtai specializes in the research, development, production, and sales of medical robot technology and systems [1] - The company was incubated by the Institute of Automation, Chinese Academy of Sciences, and is led by a team of experts including Professor Hou Zengguang, who has been involved in significant projects since 2008 [1] - Zhongke Hongtai is recognized as a pioneer in the field of vascular interventional surgical robots in China, having undertaken over 10 major projects, including the first domestic 863 program for vascular interventional surgical robots [1] Group 2: Financial Status - Zhongke Hongtai is currently not profitable [1]
金达莱:拟3000万元增资医疗机器人企业中科鸿泰